This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Vickers, A. E.M. Articles by Bentley, P. Search for Related Content PubMed PubMed Citation Articles by Vickers, A. E.M. Articles by Bentley, P. Social Bookmarking                         What's this?

Kidney Slices of Human and Rat to Characterize Cisplatin-Induced Injury on Cellular Pathways and Morphology

Preclinical Safety, Novartis Pharmaceuticals Corporation, One Health Plaza, E. Hanover, New Jersey 07936, USA, vickers_alison{at}allergan.com

Kristine Rose

Preclinical Safety, Novartis Pharmaceuticals Corporation, One Health Plaza, E. Hanover, New Jersey 07936, USA

Robyn Fisher

Vitron, Inc., Tucson, Arizona, USA

Muriel Saulnier

Preclinical Safety, Novartis Pharmaceuticals Corporation, One Health Plaza, E. Hanover, New Jersey 07936, USA

Pritam Sahota

Preclinical Safety, Novartis Pharmaceuticals Corporation, One Health Plaza, E. Hanover, New Jersey 07936, USA

Philip Bentley

Preclinical Safety, Novartis Pharmaceuticals Corporation, One Health Plaza, E. Hanover, New Jersey 07936, USA

Kidney slices represent an in vitro model that has the cellular complexity of in vivo tissue to provide insights into mechanisms of organ injury, as shown in this study with the model nephrotoxicant cisplatin. Cell pathways altered by cisplatin exposure are assessed by gene expression analysis, cell function, and morphology in human and rat kidney slices in comparison to rat kidney from an in vivo study. The acute nephrosis of the tubular epithelium induced by cisplatin in vivo was reproduced in both human and rat kidney slices, while the glomerulus appeared resistant even at high concentrations. Kidney gene expression changes of in vivo and in vitro samples were indicative of transcription, DNA damage, cell cycle, proliferation, and apoptosis that are in agreement with the mechanism of cisplatin causing DNA damage, growth arrest, and apoptosis; while genes indicative of protein damage, the disruption of transport and calcium homeostasis, cellular metabolism, and oxidative stress are pathways linked with cisplatin binding to various cellular proteins and macromolecules. Both concentration and time-dependent gene expression changes evident in the in vitro model preceded a change in tissue morphology. Functional assays confirming cell dysfunction and increased apoptosis revealed the rat kidney to be more sensitive to the effects of cisplatin than human kidney as demonstrated by significant decreases in slice ATP and GSH levels, significant increases in caspase 9 and 3 activity, p53 protein levels, and increased DNA laddering. The regional markers of proximal and distal tubular injury, alpha- and pi-glutathione S-transferases, were shown for the human kidney slices to be significantly increased by cisplatin. In this study, cisplatin-induced nephrotoxicity was demonstrated morphologically in rat and human kidney slices, and the associated gene expression and functional changes characterized the cellular pathways involved.

Key Words: Cisplatin injury • kidney slices • rat and human.

References

• Agarwal, A., Balla, J., Alam, J., Croatt, A.J., and Nath, K.A. (1995). Induction of heme oxygenase in toxic renal injury: A protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48, 1298—307.[Web of Science][Medline] [Order article via Infotrieve]
• Campbell, J.A.H., Corrigal, A.V., Guy, A., and Kirsch, R.E. (1991). Immunohistologic localization of alpha, mu, and pi class glutathione S-transferases in human tissues. Cancer 6, 1608—13.
• Chen, G., and Zeller, W.J. (1991). Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links. Anticancer Res 11, 2231—8.[Web of Science][Medline] [Order article via Infotrieve]
• Choie, D.D., Longnecker, D.S., and Del Campo, A.A. (1981). Acute and chronic cisplatin nephropathy in rats. Lab Invest 44, 397—402.[Web of Science][Medline] [Order article via Infotrieve]
• Chopra, S., Kaufman, J.S., Jones, T.W., Hong, W.K., Gehr, M.K., Hamburger, R.J., Flamenbaum, W., and Trump, B.F. (1982). Cis-diamminedichloroplatinum-induced acute renal failure in the rat. Kidney Int 21, 54—64.[Web of Science][Medline] [Order article via Infotrieve]
• Dehne, N., Lautermann, J., Petrat, F., Rauen, U., and de Groot, H. (2001). Cisplatin ototoxicity: involvement of iron and enhanced formation of super-oxide anion radicals. Toxicol Appl Pharmacol 174, 27—34.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Delmastro, D.A., Li, J., Vaisman, A., Solle, M., and Chaney, S.G. (1997). DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 39, 245— 53.[Web of Science][Medline] [Order article via Infotrieve]
• Dentino, M., Luft, F.C., Yum, M.N., Williams, S.D., and Einhorn, L.H. (1978). Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer 41, 1274—81.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Eder, P. (1997). Neoplasms. In Integrated Pharmacology (C. P. Page, M. J. Curtis, M. C. Sutter, M. J. A. Walker, and B. B. Hoffman, eds.), pp. 501— 22. Mosby International, St. Louis, MO.
• Endo, T., Kimura, O., and Sakata, M. (2002). Carrier-mediated uptake of cisplatin by the OK renal epithelial cell line. Toxicology 146, 187—95.[CrossRef]
• Erdinc, M., Erdinc, L., Nergiz, Y., and Isik, B. (2000). Potentiation of cisplatin-induced nephrotoxicity in rats with allopurinol. Exp Toxicol Pathol 52, 329—34.[Web of Science][Medline] [Order article via Infotrieve]
• Fan, J., and Bertino, J.R. (1999). Modulation of cisplatinum cytotoxicity by p53: effect of p53-mediated apoptosis and DNA repair. Mol Pharmacol 56, 966—72.[Abstract/Free Full Text]
• Fisher, R.L., Sanuik, J.T., Gandolfi, A.J., and Brendel, K. (1994). Toxicity of cisplatin and mercuric chloride in human kidney cortical slices. Human Exper Toxicol 13, 517—523.
• Gonzalez, V.M., Fuertes, M.A., Alonso, C., and Perez, J.M. (2001). Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 59, 657—63.[Free Full Text]
• Gonzalez-Vitale, J.C., Hayes, D.M., Cvitkovic, E., and Sternberg, S.S. (1978). The renal pathology in clinical trials of cis-platinum (II) and gentamicincephalothin therapies. Cancer Treat Rep 62, 693—8.[Web of Science][Medline] [Order article via Infotrieve]
• Hagrman, D., Goodisman, J., Dabrowiak, J.C., and Souid, A.-K. (2003). Kinetic study on the reaction of cisplatin with metallothionein. Drug Metabol Dispos 31, 916—23.[Abstract/Free Full Text]
• Halabe, A., Wong, N.L.M., and Sutton, R.A.L. (1991). Effect of chronic cisplatin administration on phosphate and glucose transport by the renal brush border membrane. Nephron 57, 197—200.[Web of Science][Medline] [Order article via Infotrieve]
• Hardaker, W.T. Jr, Stone, R.A., and McCoy, R. (1974). Platinum nephrotoxicity. Cancer 34, 1030—2.[Medline] [Order article via Infotrieve]
• Hosokawa, T., Okabe, M., Saito, S., Saito, T., and Kurasaki, M. (2000). Protective role of metallothionein on DNA damage in rat kidney caused by cis-diamminedichloroplatinum. Pharmacol Toxicol 86, 276— 82.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Huang, Q., Dunn, R.T., Jayadev, S., DiSorbo, O., Pack, F.D., Farr, S.B., Stoll, R.E., and Blanchard, K.T. (2001). Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 63, 196— 207.[Abstract/Free Full Text]
• Ihnat, M.A., Lariviere, J.P., Warren, A.J., La Ronde, N., Blaxall, J.R.N., Pierre, K.M., Turpie, B.W., and Hamilton, J.W. (1997). Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. Clin Cancer Res 3, 1339—46.[Abstract]
• Ishikawa, T., Wright, C.D., and Ishizuka, H. (1994). GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J Biol Chem 269, 29085—93.[Abstract/Free Full Text]
• Johnstone, R.W., Ruefli, A.A., and Smyth, M.J. (2000). Multiple physiological functions for multidrug transporter P-glycoprotein? TIBS 25, 1—6.[Medline] [Order article via Infotrieve]
• Jones, N.A., Turner, J., McIlwrath, A.J., Brown, R., and Dive, C. (1998). Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. Mol Pharmacol 53, 819—26.[Abstract/Free Full Text]
• Leibbrandt, M.E., and Wolfgang, G.H. (1995). Differential toxicity of cisplatin, carboplatin, and CI-973 correlates with cellular platinum levels in rat cortical slices. Toxicol Appl Pharmacol 132, 245—52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Leibbrandt, M.E., Wolfgang, G.H., Metz, A.L., Ozobia, A.A., and Haskins, J.R. (1995). Critical subcellular targets of cisplatin and related platinum analogs in rat proximal tubule cells. Kidney Int 48, 761—70.[Web of Science][Medline] [Order article via Infotrieve]
• Lieberthal, W., Menza, S.A., and Levine, J.S. (1998). Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol 274, F315—27.[Web of Science][Medline] [Order article via Infotrieve]
• Lieberthal, W., Triarca, V., and Levine, J. (1996). Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 270, F700—8.[Web of Science][Medline] [Order article via Infotrieve]
• Liu, J., Liu, Y., Habeebu, S.S.M., and Klaassen, C.D. (1998). Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicol Appl Pharmacol 149, 24—31.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mandic, A., Viktorsson, K., Molin, M., Akusjarvi, G., Eguchi, H., Hayashi, S.I., Toi, M., Hansson, J., Linder, S., and Shoshan, M.C. (2001). Cisplatin induces the proapoptotic conformation of Bak in a AMEKK1-dependent manner. Mol Cell Biol 21, 3684—91.[Abstract/Free Full Text]
• Nagai, N., Okuda, M., Kinoshita, M., and Ogata, H. (1996). Decomposition kinetics of cisplatin in human biological fluids. J Pharm Pharmacol 48, 918—24.[Web of Science][Medline] [Order article via Infotrieve]
• Niedner, H., Christen, R., Lin, X., Kondo, L.A., and Howell, S.B. (2001). Identification of genes that mediate sensitivity to cisplatin. Mol Pharmacol 60, 1153—60.[Abstract/Free Full Text]
• O'Brien, T., Babcock, G., Cornelius, J., Dingeldein, M., Talaska, G., Warshawsky, D., and Mitchell, K. (2000). A comparison of apoptosis and necrosis induced by hepatotoxins in HepG2 cells. Toxicol Appl Pharmacol 164, 280—90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Perez, R.P. (1998). Cellular and molecular determinants of cisplatin resistance. Eur J Cancer 34, 1535—42.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Piel, I.J., and Perlia, C.P. (1975). Phase II study of cisdichlorodiammineplatinum (II) (NS 119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancy. Cancer Chemother Rep 59, 995—9.[Web of Science][Medline] [Order article via Infotrieve]
• Plas, D.R., and Thompson, C.B. (2002). Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metabol 13, 74—8.[Web of Science]
• Rixe, O. (2000). Platinum salts: cytotoxic mechanisms of action, mechanisms of resistance of cancer cells, interactions with ionizing radiation, specificity of carboplatin. Bull Cancer 87, 7—15.[Web of Science][Medline] [Order article via Infotrieve]
• Sadowitz, P.D., Hubbard, B.A., Dabrowiak, J.C., Goodisman, J., Tacka, K.A., Aktas, K.M., Cunningham, M.J., Dubowy, R.L., and Souid, A.-K. (2002). Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs. Drug Metabol Disposit 30, 183—90.[Abstract/Free Full Text]
• Satoh, M., Shimada, A., Zhang, B., and Chiharu, T. (2000). Renal toxicity caused by cisplatinum in glutathione-depleted metallothionein-null mice. Biochem Pharmacol 60, 1729—34.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sheikh, M.S., Hollander, M.C., and Fornace, A.J., Jr. (2000). Role of Gadd45 in apoptosis. Biochem Pharmacol 59, 43—5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Shimoda, R., Achanzar, W.E., Qu, W., Nagamine, T., Takagi H., Mori, M., and Waalkes, M.P. (2003). Metallothionein is a potential negative regulator of apoptosis. Toxicol Sci 73, 294—300.[Abstract/Free Full Text]
• Shiraishi, F., Curtis, L.M., Truong, L., Poss, K., Visner, G.A., Madsen, K., Nick, H.S., and Agarwal, A. (2000). Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 278, F726—36.[Abstract/Free Full Text]
• Silkensen, J.R., Agarwal, A., Nath, K.A., Manivel, J.C., and Rosenberg, M.E. (1997). Temporal induction of clusterin in cisplatin nephrotoxicity. J Am Soc Nephrol 8, 302—5.[Abstract]
• Smith, M.L., Ford, J.M., Hollander, M.C., Bortnick, R.A., Amundson, S.A., Seo, Y.R., Deng, C.-X., Hanawalt, P.C., and Fornace, Jr., A.J. (2000). p53-Mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol 20, 3705— 14.[Abstract/Free Full Text]
• Sundberg, A.G.M., Nilsson, R., Appelkvist, E.-L., and Dallner, G. (1993). Immunohistochemical localization of and class glutathione transferases in normal human tissues. Pharmacol Toxicol 72, 321—31.[Web of Science][Medline] [Order article via Infotrieve]
• Sundberg, A.G.M., Appelkvist, E.-L., Backham, L., and Dallner, G. (1994). Urinary -class glutathione transferase as an indicator of tubular damage in the human kidney. Nephron 67, 308—16.[Web of Science][Medline] [Order article via Infotrieve]
• Tanaka, H., Ishikawa, E., Teshima, S., and Shimizu, E. (1986). Histopathological study of human cisplatin nephropathy. Toxicol Pathol 14, 247—57.[Medline] [Order article via Infotrieve]
• Thompson, K.L., Afshari, C.A., Amin, R.P., Bertram, T.A., Car, B., Cunningham, M., Kind, C., Kramer, J.A., Lawton, M., Mirsky, M., Naciff, J.M., Oreffo, V., Pine, P.S., and Sistare, F.D. (2004). Identification of platform-independent gene expression markers of cisplatin nephrotoxicity. Environ Hlth Perspec 112, 488—94.
• Vasey, P.A., Jones, N.A., and Jenkins, S. (1996). Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance. Mol Pharmacol 50, 1536—40.[Abstract]
• Wang, X.W., Xhan, O., Coursen, J.D., Khan, M.A., Kontny, H.U., Yu, L., Hollander, M.C., O'Connor, P.M., Fornace, Jr., A.J., and Harris, C.C. (1999). GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA 96, 3706—11.[Abstract/Free Full Text]
• Zhang, K., Chew, M., Yang, E.B., Wong, K.P., and Mack, P. (2001). Modulations of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms. Mol Pharmacol 59, 837—43.[Abstract/Free Full Text]

Toxicologic Pathology, Vol. 32, No. 5, 577-590 (2004)
DOI: 10.1080/01926230490508821


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Haschke, T. Vitins, S. Lude, L. Todesco, K. Novakova, R. Herrmann, and S. Krahenbuhl Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs Nephrol. Dial. Transplant., September 7, 2009; (2009) gfp456v1. [Abstract] [Full Text] [PDF]

				M. Jiang and Z. Dong Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 300 - 307. [Abstract] [Full Text] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Vickers, A. E.M. Articles by Bentley, P. Search for Related Content PubMed PubMed Citation Articles by Vickers, A. E.M. Articles by Bentley, P. Social Bookmarking                         What's this?